Sign in

NCT05028686Recruiting

Predicting Readmissions Using Omics, Biostatistical Evaluate and Artificial Intelligence

Source: ClinicalTrials.gov · Last updated 2 Sept 2021 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study is a prospective registry that aims to predict readmissions in patients with heart failure, using -omics, machine learning, patient reported outcomes, clinical data and other high-dimensional data sources.

Status (registry)
Recruiting
Study type
Observational
Enrollment
500 (estimated)
First submitted
25 Aug 2021
Start date
1 Feb 2019
Primary completion date
30 Sept 2024
Lead sponsor
Institute for Clinical Evaluative Sciences
NCT number
NCT05028686

What you commit to

  • Study type: Observational
  • Planned participants: 500
  • From 1 Feb 2019 to the primary completion date, 30 Sept 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients who cannot communicate due to dementia or severe cognitive deficits

Other

  • non-Ontario residents
  • nursing home residents
  • those who are not discharged home but are discharged to a skilled nursing facility (long-term care or chronic institution)
  • those who are unable to communicate who do not have a proxy (e.g. spouse or close family member) to facilitate communication with the patient.

Who the study is looking for

  • Any patient aged 18 years or older admitted to hospital or seen in the emergency department with heart failure defined clinically
  • The diagnosis will be guided by the Framingham criteria for HF and/or BNP. A BNP \>400 will be defined as definite heart failure and BNP 100-400 classified as possible heart failure.
  • Provides informed consent

Age in the registry: 18 years to 105 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Health Network
Coordinator of this site? Confirm its status
TorontoCanadaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.